Design of controlled release delivery systems using a modified pharmacokinetic approach: A case study for drugs having a short elimination half-life and a narrow therapeutic index

International Journal of Pharmaceutics

Volumn 261, Issue 1-2, 2003, Pages 27-41

  Sood, Anurag ^a   Panchagnula, Ramesh ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Controlled release; Diltiazem; Nifedipine; Pharmacokinetic model

Indexed keywords

DILTIAZEM; GLIPIZIDE; NIFEDIPINE; ZIDOVUDINE;

ARTICLE; CALCULATION; CONTROLLED DRUG RELEASE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; PRIORITY JOURNAL; STEADY STATE;

EID: 0042527160     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00267-9     Document Type: Article

References (18)

1. Benet, L.Z., Oie, S., Schwartz, J.B., 1996. Design and optimization of dosage regimens: pharmacokinetic data. In: Hardman, J.G., Limbird, L.E. (Eds.), Goodman and Gilman's Pharmacological Basis of Therapeutics. McGraw-Hill, New York, pp. 1707-1792.
2. Boxenbaum H.G. Physiological and pharmacokinetic factors affecting performance of sustained release dosage forms. Drug Dev. Ind. Pharm. 8:1982;1-25.
3. Chaturvedi, P.R., 1999. Pharmacokinetics. In: Methiowitz, E. (Ed.), Encyclopedia of Controlled Drug Delivery. Wiley, New York, pp. 833-851.
4. Chien, Y.W., 1982. Controlled release drug administration: logic. In: Novel Drug Delivery Systems: Fundamentals, Developmental Concepts, Biomedical Assessments. Marcel Dekker, New York, pp. 1-11.
5. Costa P., Lobo J.M.S. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 13:2001;123-133.
6. Grass, IV, G.M., Robinson, J.R., 1990. Sustained- and controlled-release drug delivery systems. In: Banker, G.S., Rhodes, C.T. (Eds.), Modern Pharmaceutics. Marcel Dekker, New York, pp. 635-671.
7. Kleinbloesem C.H., van Brummelen P., van de Linde J.A., Voogd P.J., Breimer D.D. Nifedipine: kinetics and dynamics in healthy subjects. Clin. Pharmacol. Therap. 35:1984;742-749.
8. Kleinbloesem C.H., van Brummelen P., Danhof M., Faber H., Urquhart J., Breimer D.D. Rate of increase in plasma concentration of nifedipine as a major determinant of its haemodynamic effects in man. Clin. Pharmacol. Therap. 41:1987;407-412.
9. Li, V.H.K., Lee, V.H.L., 1987. Influence of drug properties and routes of drug administration on the design of sustained and controlled release systems. In: Robinson, J.R., Lee, V.H.L. (Eds.), Controlled Drug Delivery: Fundamentals and Applications. Marcel Dekker, New York, pp. 3-94.
10. Martindale: The Extra Pharmacopoeia, 1996. In: Reynolds, J.E.F. (Ed.), Royal Pharmaceutical Society, London, pp. 916-921.
11. Ritschel, W.A., 1988. Pharmacokinetic and biopharmaceutical aspects in drug delivery. In: Tyle, P. (Ed.), Drug Delivery Devices: Fundamentals and Applications. Marcel Dekker, New York, pp. 19-79.
12. Ritschel W.A. Biopharmaceutic and pharmacokinetic aspects in the design of controlled release peroral drug delivery systems. Drug Dev. Ind. Pharm. 15:1989;1073-1103.
13. Ritschel, W.A., Kearns, G.L., 1999. Pharmacokinetic parameters of important drugs. In: Handbook of Basic Pharmacokinetics. American Pharmaceutical Association, Washington, DC, pp. 479-503.
14. Silber, B.M., Bialer, M., Yacobi, A., 1987. Pharmacokinetic/pharmacodynamic basis of controlled drug delivery. In: Robinson, J.R., Lee, V.H.L. (Eds.), Controlled Drug Delivery: Fundamentals and Applications. Marcel Dekker, New York, pp. 213-251.
15. Skelly, J.P., Barr, W.H., 1987. Regulatory assessment. In: Robinson, J.R., Lee, V.H.L. (Eds.), Contuhart, J., 1994. Role of patient compliance in clinical pharmacokinetics: review of recent research. Clin. Pharmacokinet. 27, 202-215.
16. Sorkin E.M., Clissold S.P., Brogden R.N. Nifedipine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in ishaemic heart disease, hypertension and related cardiovascular disorders. Drugs. 30:1985;182-274.
17. Theeuwes F., Bayne W. Dosage from index: an objective criterion for evaluation of controlled-release drug delivery systems. J. Pharm. Sci. 66:1977;1388-1392.
18. Urquhart J. How much compliance is enough? Pharm. Res. 13:1996;10-11.